-
10 February 2011
5 notes
India rejects patent for atazanavir
In December 2010 the Indian Patent Office denied Bristol-Myers Squibb a patent for the atazanavir bisulphate because it ‘lacked inventive ingenuity’. However the company has filed other patent applications in relation to this drug which are still pending.
Atazanavir is recommended by the World Health Organization for second-line AIDS therapy.
MORE INFORMATION
Web Updates
Regularly updated news feed of updates to the online version of Untangling the Web as well as related news articles.
